Australia's and probably the region's hope of securing a vaccine at the same time as many other countries appears to hinge on a quick decision by the federal government to back CSL in repurposing one of its manufacturing facilities to produce an overseas product - a change in language suggests it could be under consideration.
Latest Video
New Stories
-
Novartis, Monash University and Monash Health partner for heart health
May 9, 2024 - - Latest News -
New research paper highlights potential but current failings of digital health
May 8, 2024 - - Latest News -
Parliamentary inquiry recommends reforming access arrangements for lobbyists
May 8, 2024 - - Latest News -
Bristol Myers Squibb announces new country medical director for Australia and NZ
May 8, 2024 - - Latest News -
Island announces reallocation of US grant funding to support dengue fever trial
May 8, 2024 - - Latest News -
Launch of new Queensland-based research and manufacturing hub targeting precision medicines
May 8, 2024 - - Latest News -
New TGA approvals for UCB's interleukin inhibitor
May 8, 2024 - - Latest News